bridge biotec, thinking beyond

menu.png

Come and hear about Bridge Biotec's research at an event near you soon.
Mike and the team would be delighted to talk about our plans for the future of inflammation treatment and you could play a part by investing in our work. See our news and list of events below.

 

News & Events

Bridge Biotec's guide to events and the latest developments in our work.

master investor show 2019

Master Investor - 6th April 2019

Come and meet Mike davies of Bridge Biotec.

Venue: Business Design Centre in Islington, 52 Upper Street, London N1 0Q

Update: Thanks to all who attended, see you at the next event.

bio europe spring 2019

Bio-Europe Spring - March 25-27 2019

Bridge will be presenting at 'Bio-Europe Spring'

Venue: Messe Wien Exhibition and Congress Center, Vienna, Austria

bio-europe spring 2019 information

LSX World Congress - February 2019

Bridge Biotec will be presenting at the LSX World Congress in London on Tuesday 5th February.

#LSXWORLD

BioSeed London 2019 - January 2019

Bridge Biotec will be presenting research results at the BioSeed Showcase in London on 16th Jan 2019. Find out how you can invest in our safe and effective treatments of inflammatory diseases.

Update: Thanks to all who attended this event, it was great to meet everyone and thanks for listening!
Here's to an inflammation free future.

bioseed 2019

biotech showcase san francisco jan-2019

Biotech Showcase 2019 - January 2019

Bridge Biotec will be presenting research results at the Biotech Showcase in San Francisco 7-10 Jan 2019. Find out how you can invest in our safe and effective treatments of inflammatory diseases.

Update: Thanks to everyone we met at this great event.
Here's to an inflammation free future.

 events-480x150.png

press-480x150.png

IBD Innovate event - 13th November 2018

Successfully presented poster at Crohns and Colitis meeting, The New York Academy of Medicine

Pitching to Angel Investors - October 2018

Initial Seed funding of £30,000

Research results - September 2018

Exciting results showing cellular delivery and activity of the peptides using the nanotech delivery

Licencing attained - October 2017

Licenced AstraZeneca developed, dormant peptides (from Blueberry Therapeutics)

October 2017: Licenced the nanoparticle delivery technology from Tecrea Limited

Bridge Founded - 8th November 2016

 

youtube bridge biotecbridge biotec facebookbridge biotec twitterbridge biotec linkedin

Contact

Email: contact@bridgebiotec.com
UK: +44 (0) 20 3097 1979
US: +1 212 863 9902

©2018 Bridge Biotec Ltd.

The BioHub at Alderley Park
Mereside, Alderley Park
Macclesfield
SK10 4TG